Form 4: Health Catalyst Executive Sells Shares to Cover Tax Obligations
SEC Form 4
Kevin Lee Freeman, Chief Commercial Officer of Health Catalyst, Inc., sold 4,540 shares of common stock to cover tax withholding obligations related to the vesting of restricted stock units.
Summary
- On March 1, 2024, Kevin Lee Freeman, the Chief Commercial Officer of Health Catalyst, Inc. (HCAT), disposed of 4,540 shares of common stock.
- The transaction was executed at a price of $8.0512 per share.
- The sale was mandated by the issuer to cover tax withholding obligations associated with the vesting of restricted stock units.
- Following the transaction, Freeman still beneficially owns 276,604 shares of Health Catalyst common stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the transaction is a routine sale to cover tax obligations and doesn't reflect a change in the executive's outlook on the company.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders. This transaction appears to be routine, related to tax obligations, and doesn't necessarily indicate a change in the executive's confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 03/01/2024 | Date of the stock sale transaction. |
| 03/05/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.